Science-based, accessible information about CBD, CBG, CBN, CBC, and the human endocannabinoid system. Written for patients, reviewed by healthcare professionals.
Informação baseada em ciência e acessível sobre CBD, CBG, CBN, CBC e o sistema endocanabinoide humano. Escrito para pacientes, revisado por profissionais de saúde.
Cannabinoids are natural compounds found in the Cannabis sativa plant. Hemp-derived cannabinoids interact with your body's own endocannabinoid system to support balance and wellness. The five cannabinoids Medicanna USA specializes in are:
Canabinoides são compostos naturais encontrados na planta Cannabis sativa. Os cinco canabinoides em que a Medicanna USA se especializa são:
Canabiodiol
The most researched cannabinoid. CBD is non-psychoactive and has been studied for anxiety, inflammation, sleep, and neuroprotection. It is the only cannabinoid with FDA-approved pharmaceutical applications (Epidiolex®).
O canabinoide mais pesquisado. Não é psicoativo e foi estudado para ansiedade, inflamação, sono e neuroproteção.
Canabigerol
Called the "mother of all cannabinoids" — all other cannabinoids start as CBG before enzymatic conversion. CBG is being researched for its antibacterial, anti-inflammatory, and neuroprotective properties, and may support focus and gut health.
Chamado de "a mãe de todos os canabinoides". Pesquisado por propriedades antibacterianas, anti-inflamatórias e neuroprotetoras.
Canabinol
A mildly psychoactive cannabinoid produced as THC ages. CBN is best known for its sedative properties and is studied as a sleep aid. It may also have antibacterial and anti-inflammatory effects.
Melhor conhecido por propriedades sedativas. Estudado como auxiliar do sono, com efeitos antibacterianos e anti-inflamatórios.
Cannabicromeno
One of the three most common cannabinoids, CBC does not bind strongly to CB1 or CB2 receptors but interacts with other pain-related receptors. Studied for analgesic, anti-inflammatory, and mood-supporting properties.
Estudado por propriedades analgésicas, anti-inflamatórias e de apoio ao humor. Não se liga fortemente aos receptores CB1 ou CB2.
Canabidivarina
A structural analog of CBD (propyl homolog). CBDV is currently in clinical trials for autism spectrum disorder and Rett syndrome. It has shown anticonvulsant properties and is non-psychoactive.
Análogo estrutural do CBD. Em ensaios clínicos para transtorno do espectro autista e síndrome de Rett. Propriedades anticonvulsivantes.
O Efeito Entourage
Research suggests cannabinoids work synergistically — each enhancing the therapeutic effect of the others. Full-spectrum products preserve this natural synergy, while broad-spectrum removes THC but keeps all other cannabinoids.
Pesquisas sugerem que os canabinoides funcionam de forma sinérgica. Produtos full-spectrum preservam essa sinergia natural.
The endocannabinoid system (ECS) is a complex cell-signaling system present in all mammals, including humans. Discovered in the early 1990s, it plays a key role in regulating a range of functions and processes including:
O sistema endocanabinoide (SEC) é um sistema complexo de sinalização celular presente em todos os mamíferos, incluindo humanos. Descoberto no início dos anos 1990, desempenha papel fundamental na regulação de diversas funções:
Dosage varies by individual, condition, and product type. Always start low and go slow. Consult a physician before starting cannabinoid therapy, especially if taking medications.
A dosagem varia por indivíduo, condição e tipo de produto. Sempre comece devagar e aumente gradualmente. Consulte um médico antes de iniciar a terapia com canabinoides, especialmente se estiver tomando medicamentos.
| Condition / Condição | Starting Dose / Dose Inicial | Typical Range / Faixa Típica | Product Type / Tipo | Notes / Notas |
|---|---|---|---|---|
| Anxiety / Ansiedade | 10–15mg CBD | 20–60mg/day | CBD Oil / Tincture | Take AM + PM / Tomar manhã + noite |
| Chronic Pain / Dor Crônica | 15–20mg CBD | 30–100mg/day | Oil, Topical / Óleo, Tópico | Topical for localized relief / Tópico para alívio localizado |
| Sleep / Sono | 15mg CBN | 15–30mg CBN | CBN Oil | 30–60 min before bed / Antes de dormir |
| Epilepsy / Epilepsia | Per physician / Por médico | Highly variable | CBD Oil / Óleo | ANVISA prescription required / Prescrição ANVISA obrigatória |
| Inflammation / Inflamação | 10mg CBD | 20–50mg/day | CBD + CBC Oil | Combined CBD+CBC may enhance effect / CBD+CBC combinados |
| Focus / Foco | 10mg CBG | 10–40mg/day | CBG Oil, Gummies | Morning use preferred / Uso matinal preferível |
| Autism Spectrum / TEA | Per physician / Por médico | Highly variable | CBDV Oil | Requires specialist guidance / Requer orientação especializada |
Sources: Project CBD, PubMed clinical reviews, ANVISA technical reports | Always titrate slowly. Individual responses vary significantly.
A Certificate of Analysis (CoA) is a third-party laboratory document that verifies what is in a cannabinoid product. Every Medicanna USA batch has a public CoA. Here is how to verify it:
Um Certificado de Análise (CoA) é um documento de laboratório terceirizado que verifica o que há em um produto canabinoide. Cada lote da Medicanna USA possui um CoA público.
Every Medicanna USA product label has a batch/lot number and QR code linking directly to the CoA in our patient portal. / Cada rótulo Medicanna USA tem número de lote e QR code.
Check that the testing laboratory is ISO/IEC 17025 accredited and independent from the manufacturer. / Verifique se o laboratório é acreditado pela ISO/IEC 17025 e independente do fabricante.
The potency panel shows exact mg/g concentrations of CBD, THC, CBG, CBN, CBC, and CBDV. Verify the label claim matches. / O painel de potência mostra as concentrações exatas de cada canabinoide.
For legal hemp products in the USA and for ANVISA-authorized imports to Brazil, total THC must be ≤0.3%. / Para produtos legais nos EUA e importações ANVISA para o Brasil, o THC total deve ser ≤0,3%.
All Medicanna USA CoAs include pesticide screening and heavy metal analysis. Results should show "ND" (Not Detected) or values below action limits. / Todos os CoAs incluem pesticidas e metais pesados.
CoAs should be dated within 12 months of purchase. Cannabinoid potency can degrade over time. / O CoA deve ser datado dentro de 12 meses da compra.
Selected peer-reviewed publications and regulatory documents on cannabinoid science. / Publicações científicas revisadas por pares sobre a ciência dos canabinoides.
Landmark RCT showing CBD significantly reduced seizure frequency vs placebo in patients with Dravet Syndrome. Led to FDA approval of Epidiolex.
Systematic review finding preclinical evidence strongly supports CBD as a treatment for multiple anxiety disorders.
Survey of 2,409 CBD users showing the most common uses are self-treating anxiety, sleep disorders, and pain.
Review of clinical trials demonstrating the analgesic potential of CBD-based treatments for chronic pain conditions.
Brazilian regulation governing the authorization and import of cannabis-based products for individual medical use. Establishes the legal framework for patients to import from companies like Medicanna USA.
Now that you understand the science, explore our products, find a doctor, or contact us for guidance.
Explore nossos produtos, encontre um médico ou entre em contato.